Dr. Carol Ann Huff, Director of the Mutiple Myeloma Program and the Sidney Kimmel Comprehensive Cancer Center in Baltimore, will present case scenarios which will address evidence basis for selecting initial therapy for patients with MM, discuss strategies to reduce the incidence and severity of peripheral neuropathy in patients with MM; and discuss emerging therapeutic strategies for patients with MM